Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Monoclonal Antibody to Inhibit IL33 for Autoimmune Disorders by Eli Lilly and Co for Autoimmune Disorders: Likelihood of Approval
Monoclonal Antibody to Inhibit IL33 for Autoimmune Disorders is under clinical development by Eli Lilly and Co and currently in...